52 related articles for article (PubMed ID: 10456672)
1. CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy.
Al Barashdi MAS; Ali A; McMullin MF; Mills K
Ann Hematol; 2024 Jan; 103(1):73-88. PubMed ID: 37917373
[TBL] [Abstract][Full Text] [Related]
2. Fludarabine Enhances Radiosensitivity by Promoting Ferroptosis in B-Cell Lymphoma.
Long Q; Tao H; Wang P; Wu B; Zhu Q; Chen H; Lao G; Yang Y; Liu G; Liu S; Wu Y
Radiat Res; 2024 Mar; 201(3):224-239. PubMed ID: 38235545
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression.
Jen WY; Sasaki K; Loghavi S; Wang SA; Qiao W; Borthakur G; Ravandi F; Kadia TM; Issa GC; Short NJ; Yilmaz M; Daver NG; DiNardo CD
Br J Haematol; 2024 Apr; ():. PubMed ID: 38603594
[TBL] [Abstract][Full Text] [Related]
4. MDS and AML show elevated fractions of CD34-positive blast cell populations with a high anti-apoptotic versus proliferation ratio.
Mestrum SGC; Roanalis BYV; de Wit NCJ; Drent RJM; Boonen BT; van Hemert WLW; Hopman AHN; Ramaekers FCS; Leers MPG
Leuk Res; 2024 May; 142():107520. PubMed ID: 38776565
[TBL] [Abstract][Full Text] [Related]
5. Piplartine eliminates CD34 + AML stem/progenitor cells by inducing oxidative stress and suppressing NF-κB signalling.
Rodrigues ACBDC; Silva SLR; Dias IRSB; Costa RGA; Oliveira MS; Soares MBP; Dias RB; Valverde LF; Rocha CAG; Johnson EM; Pina C; Bezerra DP
Cell Death Discov; 2024 Mar; 10(1):147. PubMed ID: 38503729
[TBL] [Abstract][Full Text] [Related]
6. Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virus.
Peng J; Wang S; Fan W; Li S; Wu Y; Mou X; Wang J; Tong X
Onco Targets Ther; 2018; 11():6887-6900. PubMed ID: 30410347
[TBL] [Abstract][Full Text] [Related]
7. Heteronemin, a marine natural product, sensitizes acute myeloid leukemia cells towards cytarabine chemotherapy by regulating farnesylation of Ras.
Saikia M; Retnakumari AP; Anwar S; Anto NP; Mittal R; Shah S; Pillai KS; Balachandran VS; Peter V; Thomas R; Anto RJ
Oncotarget; 2018 Apr; 9(26):18115-18127. PubMed ID: 29719594
[TBL] [Abstract][Full Text] [Related]
8. Prolonged intracellular accumulation of light-inducible nanoparticles in leukemia cells allows their remote activation.
Boto C; Quartin E; Cai Y; Martín-Lorenzo A; Cenador MBG; Pinto S; Gupta R; Enver T; Sánchez-García I; Hong D; Pires das Neves R; Ferreira L
Nat Commun; 2017 May; 8():15204. PubMed ID: 28492285
[TBL] [Abstract][Full Text] [Related]
9. Demographic and clinical characteristics of acute myeloid leukaemia diagnosed and treated at the tertiary level in Afghanistan.
Noor S; Haidary AM; Yosufzai AW; Niazai M; Noor S; Nasir N; Shinwari A; Saadaat R
Br J Haematol; 2023 Nov; 203(3):404-410. PubMed ID: 37609793
[TBL] [Abstract][Full Text] [Related]
10. Cytarabine-induced peripheral neuropathy in a young patient with acute myeloid leukemia: a case report.
Karki K; Adhikari S; Shrestha S; Bhandari J; Baral B; Baral A
Ann Med Surg (Lond); 2024 May; 86(5):3082-3085. PubMed ID: 38694396
[TBL] [Abstract][Full Text] [Related]
11. Combination of the PI3K inhibitor Idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative effects in B lymphoblastic leukaemia cell lines.
Sklarz LM; Gladbach YS; Ernst M; Hamed M; Roolf C; Sender S; Beck J; Schütz E; Fischer S; Struckmann S; Junghanss C; Fuellen G; Murua Escobar H
Cancer Cell Int; 2020; 20():390. PubMed ID: 32817744
[TBL] [Abstract][Full Text] [Related]
12. Has Drug Repurposing Fulfilled its Promise in Acute Myeloid Leukaemia?
Valli D; Gruszka AM; Alcalay M
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32560371
[TBL] [Abstract][Full Text] [Related]
13. Revumenib (SNDX-5613): a promising menin inhibitor for the management of relapsed and refractory acute myeloid leukaemia (AML).
Hussain H; Zaidi SMF; Hasan SM; Jahan AS; Rangwala BS; Rangwala HS; Ali M; Farah AA
Ann Med Surg (Lond); 2024 May; 86(5):2379-2381. PubMed ID: 38694289
[No Abstract] [Full Text] [Related]
14. Myeloid Leukæmia.
Field CE
Proc R Soc Med; 1939 Apr; 32(6):604-6. PubMed ID: 19991883
[No Abstract] [Full Text] [Related]
15. Splenectomy in Myeloid Leukæmia.
Carling ER; Carlill H; Pulvertaft RJ
Proc R Soc Med; 1933 Feb; 26(4):373. PubMed ID: 19989134
[No Abstract] [Full Text] [Related]
16. Overexpression of the toll-like receptor (TLR) signaling adaptor MYD88, but lack of genetic mutation, in myelodysplastic syndromes.
Dimicoli S; Wei Y; Bueso-Ramos C; Yang H; Dinardo C; Jia Y; Zheng H; Fang Z; Nguyen M; Pierce S; Chen R; Wang H; Wu C; Garcia-Manero G
PLoS One; 2013; 8(8):e71120. PubMed ID: 23976989
[TBL] [Abstract][Full Text] [Related]
17. Effect of all-trans retinoic acid on chemotherapy induced apoptosis and down-regulation of Bcl-2 in human myeloid leukaemia CD34 positive cells.
Ahmed N; Laverick L; Sammons J; Baumforth KR; Hassan HT
Leuk Res; 1999 Aug; 23(8):741-9. PubMed ID: 10456672
[TBL] [Abstract][Full Text] [Related]
18. Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells.
Ahmed N; Laverick L; Sammons J; Zhang H; Maslin DJ; Hassan HT
Anticancer Res; 2001; 21(5):3519-23. PubMed ID: 11848518
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 protein in human myeloid leukaemia cells and its down-regulation during chemotherapy-induced apoptosis.
Ahmed N; Sammons J; Hassan HT
Oncol Rep; 1999; 6(2):403-7. PubMed ID: 10023011
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
